<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The use of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> has been associated with the delayed appearance of <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We report a woman who developed <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> leading to <z:hpo ids='HP_0004808'>acute myelocytic leukemia</z:hpo>, 4 years after receiving 13 g of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> over 6 months for severe <z:e sem="disease" ids="C0031036" disease_type="Disease or Syndrome" abbrv="">polyarteritis nodosa</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Cytogenetic abnormalities typical of damage induced by <z:chebi fb="0" ids="22333">alkylating agents</z:chebi>, including partial deletions of chromosomes 5 and 7, were present </plain></SENT>
<SENT sid="3" pm="."><plain>This case represents the first reported occurrence of <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> in <z:e sem="disease" ids="C0031036" disease_type="Disease or Syndrome" abbrv="">polyarteritis nodosa</z:e> </plain></SENT>
</text></document>